Rankings
▼
Calendar
EDIT Q1 2025 Earnings — Editas Medicine, Inc. Revenue & Financial Results | Market Cap Arena
EDIT
Editas Medicine, Inc.
$256M
Q1 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$5M
+310.4% YoY
Gross Profit
$5M
100.0% margin
Operating Income
-$76M
-1635.1% margin
Net Income
-$76M
-1633.5% margin
EPS (Diluted)
$-0.92
QoQ Revenue Growth
-84.8%
Cash Flow
Operating Cash Flow
-$48M
Free Cash Flow
-$48M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$264M
Total Liabilities
$201M
Stockholders' Equity
$62M
Cash & Equivalents
$139M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$5M
$1M
+310.4%
Gross Profit
$5M
-$274,000
+1800.0%
Operating Income
-$76M
-$67M
-13.7%
Net Income
-$76M
-$62M
-22.8%
Revenue Segments
Reportable Segment
$5M
100%
← FY 2025
All Quarters
Q2 2025 →